Literature DB >> 30670491

Depression Stresses the Immune Response and Promotes Prostate Cancer Growth.

Hemn Mohammadpour1, Mark J Bucsek2, Bonnie L Hylander2, Elizabeth A Repasky2.   

Abstract

Depression induces secretion of neuropeptide Y from prostate cancer cells, which, in turn, recruits myeloid-derived suppressor cells (MDSC) to the tumor; tumor cells and MDSCs secrete IL6, which activates STAT3 within cancer cells. Prostate cancer samples from depressed patients reveal a similar phenotype, suggesting new treatment strategies based upon blockade of β2-adrenergic receptors and/or neuropeptide Y.See related article by Cheng et al., p. 2621. ©2019 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30670491      PMCID： PMC6467802          DOI： 10.1158/1078-0432.CCR-18-3980

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  12 in total

1.  Depression-Induced Neuropeptide Y Secretion Promotes Prostate Cancer Growth by Recruiting Myeloid Cells.

Authors:  Yan Cheng; Xin-Ying Tang; Yi-Xuan Li; Dan-Dan Zhao; Qiu-Hua Cao; Hong-Xi Wu; Hong-Bao Yang; Kun Hao; Yong Yang
Journal:  Clin Cancer Res       Date:  2018-11-30       Impact factor: 12.531

2.  Sympathetic Neuronal Activation Triggers Myeloid Progenitor Proliferation and Differentiation.

Authors:  Sathish Babu Vasamsetti; Jonathan Florentin; Emilie Coppin; Lotte C A Stiekema; Kang H Zheng; Muhammad Umer Nisar; John Sembrat; David J Levinthal; Mauricio Rojas; Erik S G Stroes; Kang Kim; Partha Dutta
Journal:  Immunity       Date:  2018-06-26       Impact factor: 31.745

3.  Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients.

Authors:  Susan K Lutgendorf; Koen DeGeest; Laila Dahmoush; Donna Farley; Frank Penedo; David Bender; Michael Goodheart; Thomas E Buekers; Luis Mendez; Gina Krueger; Lauren Clevenger; David M Lubaroff; Anil K Sood; Steve W Cole
Journal:  Brain Behav Immun       Date:  2010-10-16       Impact factor: 7.217

4.  Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice.

Authors:  Kathleen M Kokolus; Ying Zhang; Jeffrey M Sivik; Carla Schmeck; Junjia Zhu; Elizabeth A Repasky; Joseph J Drabick; Todd D Schell
Journal:  Oncoimmunology       Date:  2017-12-21       Impact factor: 8.110

5.  Social Stress Mobilizes Hematopoietic Stem Cells to Establish Persistent Splenic Myelopoiesis.

Authors:  Daniel B McKim; Wenyuan Yin; Yufen Wang; Steve W Cole; Jonathan P Godbout; John F Sheridan
Journal:  Cell Rep       Date:  2018-11-27       Impact factor: 9.423

Review 6.  Ecoimmunology for psychoneuroimmunologists: Considering context in neuroendocrine-immune-behavior interactions.

Authors:  Gregory E Demas; Elizabeth D Carlton
Journal:  Brain Behav Immun       Date:  2014-09-10       Impact factor: 7.217

Review 7.  Therapeutic potential of neuropeptide Y (NPY) receptor ligands.

Authors:  Shaun P Brothers; Claes Wahlestedt
Journal:  EMBO Mol Med       Date:  2010-11       Impact factor: 12.137

Review 8.  Manipulation of Ambient Housing Temperature To Study the Impact of Chronic Stress on Immunity and Cancer in Mice.

Authors:  Bonnie L Hylander; Christopher J Gordon; Elizabeth A Repasky
Journal:  J Immunol       Date:  2019-02-01       Impact factor: 5.426

9.  Modulation of ambient temperature promotes inflammation and initiates atherosclerosis in wild type C57BL/6 mice.

Authors:  Daniel A Giles; Bhama Ramkhelawon; Elizabeth M Donelan; Traci E Stankiewicz; Susan B Hutchison; Rajib Mukherjee; Monica Cappelletti; Rebekah Karns; Christopher L Karp; Kathryn J Moore; Senad Divanovic
Journal:  Mol Metab       Date:  2016-09-21       Impact factor: 7.422

Review 10.  Adrenergic Signaling: A Targetable Checkpoint Limiting Development of the Antitumor Immune Response.

Authors:  Guanxi Qiao; Minhui Chen; Mark J Bucsek; Elizabeth A Repasky; Bonnie L Hylander
Journal:  Front Immunol       Date:  2018-02-06       Impact factor: 7.561
View more
  1 in total

Review 1.  Antitumor effects of targeting myeloid-derived suppressive cells.

Authors:  Dong Zeng; Haixia Long; Bo Zhu
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.